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Abstract
Successful and consistent isolation of primary human hepatocytes remains a challenge for both cell-based therapeutics/
transplantation and laboratory research. Several centres around the world have extensive experience in the isolation of
human hepatocytes from non-diseased livers obtained from donor liver surplus to surgical requirement or at hepatic
resection for tumours. These livers are an important but limited source of cells for therapy or research. The capacity to
isolate cells from diseased liver tissue removed at transplantation would substantially increase availability of cells for
research. However no studies comparing the outcome of human hepatocytes isolation from diseased and non-diseased
livers presently exist. Here we report our experience isolating human hepatocytes from organ donors, non-diseased
resected liver and cirrhotic tissue. We report the cell yields and functional qualities of cells isolated from the different types
of liver and demonstrate that a single rigorous protocol allows the routine harvest of good quality primary hepatocytes
from the most commonly accessible human liver tissue samples.
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Introduction
High quality primary human hepatocytes are a valuable
resource for biomedical research, the pharmaceutical industry
and therapeutic purposes [1–4]. It is becoming widely accepted
that the majority of hepatocyte cell lines lack many important
aspects of primary cell function and are unlikely to be used
therapeutically. Primary hepatocytes are thus becoming increas-
ingly used in drug development to evaluate key human-specific
drug properties such as metabolic fate, drug-drug interactions, and
drug toxicity. However the quality and metabolic/functional
activity of the cells is variable. Thus human hepatocyte research
would be greatly assisted if hepatocytes could be consistently
isolated from human liver tissue obtained through hepatobiliary
and transplant programs. Previously authors have suggested
protocols for successful human hepatocyte isolation but these
have applied exclusively to tissue obtained from organ donors [5–
6] or from non-diseased tissue removed at surgical resection for
liver tumours [1,7–10]. Recent work conducted within our
laboratory has shown for the first time that human hepatocytes
isolated from various cohorts of non-diseased and diseased livers
exhibit different responses when used in functional studies [4].
Thus comparative studies need to be carried out in cells isolated
from different hepatic diseases.
The isolation of human hepatocytes from steatotic liver tissue
has been difficult [6] and although detailed protocols have been
described [3] the overall results are so variable in terms of yield
and quality of cells that it has been suggested it is not economically
viable to attempt hepatocytes isolation from diseased liver tissue
[6]. Most published studies have reported outcomes of human
hepatocyte isolation from normal resected [1] and donor liver
tissue [2,3]. Here we report our experience of isolating human
hepatocytes from all types of livers including normal donor tissue,
cut-down liver, normal resected liver tissue and cirrhotic liver
disease. We do so in the hope that other researchers in this
challenging field may benefit from our experience and make
informed decisions on how best to isolate cells for their own
studies.
Methods
Ethics Statement
Liver tissue was obtained from surgical procedures carried out
at the Queen Elizabeth Hospital, Birmingham, UK. Ethical
approval for the study was granted by the Local Research Ethics
Committee (LREC) (reference number 06/Q702/61). Informed
written consent was obtained from all participants involved in the
study.
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All liver tissue was obtained from fully consenting patients
undergoing liver transplantation for a variety of end-stage liver
diseases. Human hepatocytes were isolated from explanted
diseased livers from patients with alcoholic liver disease (ALD),
biliary cirrhosis (primary biliary cirrhosis (PBC) and primary
sclerosing cholangitis (PSC) and a variety of other end-stage liver
diseases (Cystic Fibrosis, Cryptogenic Fibrosis, Alpha-1-antitypsin
Deficiency, Autoimmune Hepatitis and Non-alcoholic Steatohe-
patitis). Hepatocytes were also isolated from tissue taken from
patients who had undergone hepatic resections for liver metastasis
from colorectal carcinoma, hepatic resections carried out for
benign disease (recurrent cholangitis, focal nodular hyperplasia
and haemangiomas), cut-down specimens and normal donor tissue
surplus to surgical requirements. For the purposes of the study,
liver tissue obtained from resections for benign lesions was
included in the normal liver group whereas liver tissue obtained
from hepatic resections carried out for metastatic disease was
classified as normal resected tissue as is referred to as this hereafter.
All the patients included in this latter group had received pre-
operative chemotherapy to reduce tumour mass prior to surgery.
For all liver tissue specimens we adopted a stringent and rigorous
procurement and isolation protocol. Following explantation or
resection, specimens were immediately placed on ice in a sterile
sealed draw string bag and processed within 1 hour. There were
however exceptions to this, in cases were hepatic resections or liver
transplants were carried out at in the late evening or at night, liver
tissue was kept sterile on ice overnight. The significant exception to
this protocol was in the use of donor liver tissue. In all cases the donor
liver was assessed for transplantation by the clinical team at the
Queen Elizabeth Hospital, Birmingham and if deemed unsuitable for
liver transplantation it was then used for hepatocyte isolation. Precise
time between explantation or resection of the liver and commence-
ment of the isolation procedure was recorded in each case.
In isolation procedures where donor liver or liver explants were
used, liver wedges were obtained from either the segments II/III
or segments V/VI. In procedures where normal resected tissue
was used for isolating human hepatocytes, only patients who had
undergone right hemihepatectomies were deemed suitable by our
pathologist to obtain normal resected liver tissue from. This was
obtained in all cases from segments V/VI. Liver wedges were cut
and weighed by a trained pathologist. To eliminate interperson
variability, the subsequent hepatocyte isolation procedures were
carried out by a single individual (R.H.B).
Hepatocyte isolations were carried out using a modified ‘two-
stage’ collagenase procedure developed by Berry and Friend [11].
This method has been adapted by several laboratories to isolate
human hepatocytes [12–14]. After the liver wedge was cut it was
placed into ice-cold Dulbecco’s Modified Eagles Medium (DMEM)
(Gibco, Paisley, UK). The liver was then washed through the
exposed, cut, vessels with Phosphate-buffered Saline (PBS), pH 7.2.
This was to remove any remaining blood from within the liver
wedge and to identify two suitable vessels that could be used for
cannulation and subsequent perfusion of buffers. The vessels for
cannulation were chosen using two criteria. Firstly, when washing
the liver through with PBS it is apparent which parts of the wedge
were being ‘perfused’ by that particular vessel, hence the greater the
liver area ‘perfused’ the more favourable the vessel was thought to
be and secondly the two vessels should be in different parts of the
liver wedge to ensure optimum perfusion of the whole wedge.
Subsequently two 20 gauge cannulae (Becton-Dickinson, Oxford,
UK) were sutured into the chosen vessels using a 3/0 prolene
(Covidien, Hampshire, UK) purse string suture (Figure 1). The
cannulae were then primed with PBS to ensure that subsequent
fluids used for perfusion would run correctly. The final stage of
preparing the liver wedge involved oversewing any major vessels
that were present on the cut surface of the liver wedge, to ensure
minimal loss of perfusion fluids. This also helped maintain pressure
within the liver wedge throughout the isolation procedure.
The perfusion circuit was set up according to the widely
established routine protocol. One end of the perfusion tube was
fed into the perfusion buffer, the central segment of the tubing was
within the pump (Model IP 505Du, Watson-Marlow Ltd,
Falmouth, UK), and the two outlets of the tubing were connected
to the sutured cannulae. The liver wedge was held over a
container during the procedure. This container also contained the
waste tubing which connected the container to the waste pot. At
the commencement of the procedure, all rubber tubing remained
‘open’ allowing the free flow of perfusion and waste fluids. All
buffers used in the isolation procedure were pre-warmed to 42uC
in a water bath. At this stage, liver wedges were first perfused with
‘non-recirculating’ wash buffer (10 mM 4-(2-hydroxylethyl)-1-
piperazineethanesulfonic acid (HEPES) pH 7.2) (Sigma, Dorset,
UK) at room temperature using a flow rate of 75 ml/min,
ensuring flushing out of blood within the liver vasculature. After
this, the wedge was perfused with chelating solution (non-
recirculating) (10 mM HEPES, 0.5 mM Ethylene Glycol Tetra-
acetic Acid (EGTA), pH 7.2) (Sigma) in order to disrupt cell
adhesion to the underlying matrix. This was followed by further
perfusion with (non-recirculating) wash buffer to remove any
remaining EGTA from the liver as the enzymes used to dissociate
the liver are dependent upon calcium and magnesium for
activation. At this point the waste tubing was clamped to allow
recirculation of the enzymatic buffer. Enzyme buffer perfusion
solution was made up as follows: Fresh aliquots of enzymes were
removed from 220uC storage and dissolved in Hank’s Balanced
Salt Solution (HBSS) (Gibco, Paisley, UK) that had been
supplemented with calcium chloride (5 mM) and magnesium
chloride (5 mM). Following enzyme dissolution the solution was
Figure 1. Preparation of the Encapsulated Liver Wedge Prior to
Perfusion. Isolation of human hepatocytes was performed from liver
wedges (50–413 g). Liver wedges had one cut face (CF) with the
remainder of the hepatic capsule being left intact. After washing the
liver through exposed vessels with PBS, 20 G cannulae were sutured
into suitable vessels with 3/0 prolene purse string sutures. The
remaining vessels were oversewn using continuous 3/0 prolene sutures
(arrowed). The liver wedge was then ready to be used for the perfusion
isolation protocol.
doi:10.1371/journal.pone.0018222.g001
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back into the HBSS solution. Specifically, 0.5% w/v Collagenase
A (from Clostridium Histolyticum, Roche, Hertford, UK, Lot
number 70273822), 0.25% w/v Protease (Type XIV from
Streptomyces Griseus, Sigma, Lot number 076K1177, 4.5 units/
mg), 0.125% w/v Hyaluronidase (from bovine testes, Sigma, Lot
number 025K7015, 451 units/mg) and 0.05% w/v Deoxyribo-
nuclease (from bovine pancreas, Sigma, Lot number 107K7013,
552 units/mg) were the enzymes used. The liver wedge was
perfused with the recirculating enzyme solution at 37uC using a
flow rate 75 ml/min for between 1–19 min, this time was
designated to be the perfusion time. The decision to stop perfusion
was made when the cut surface of the liver allowed the admission
of a digit. At this point the perfusion tubing and cannulae were
removed and the liver was then transferred to a sterile glass dish
and dissociated using manual force whilst in DMEM supplement-
ed with 10% v/v heat inactivated foetal calf serum (Gibco), 2 mM
glutamine (Gibco), 20,000 units/l Penicillin, and 20 mg/ml
Streptomycin (Gibco) and 2.5 mg/ml Gentamycin. Following
manual dissociation of the liver wedge the suspension was passed
through a sterile nylon mesh of 250 mm (John Staniar Ltd,
Manchester, UK) followed by a sterile nylon mesh of 60 mm (John
Staniar Ltd). Suspensions were then washed three times at 506g
for 10 min at 4uC in supplemented media.
Immediately after washing, cell viability was determined by
trypan blue dye exclusion and deemed acceptable if greater than
.50% at this stage. Hepatocytes were then plated out in
supplemented media. If viability was lower but total cell yield
was high, Percoll density gradient centrifugation of cell suspensions
was carried out to improve yield of viable cells. Percoll (Sigma) was
made by adding to PBS pH 7.2 to density of 4.5 g/ml. Percoll was
added to cell suspensions and washed at 3006g for 30 min at room
temperature. Cell viability was again determined by trypan blue
dye exclusion and if improved to .50% cells were plated out at
5610
5 per well in supplemented media for 2 hours onto type 1 rat
collagen coated plates to allow adherence of cells. After this period,
the media was changed to Arginine-free Williams E media (Sigma)
containing Hydrocortisone (2 ug/ml), Insulin (0.124 U/ml),
Glutamine (2 mM), Penicillin (20,000 units/l), Streptomycin
(20 mg/l) and Ornithine (0.4 mmol/l). The media was exchanged
every 24 hours and for subsequent functional studies, cells were
used within 2 days. Figure 2 shows the morphology of primary
human hepatocyte isolated from PBC livers at different time points
following successful isolation. The morphology of human hepato-
cytes isolated from normal tissue, biliary cirrhosis, ALD and
normal resected liver tissue three days after successful isolation are
also demonstrated (Figure 2b). As Figure 3 demonstrates, primary
human hepatocytes showed characteristic phenotypic features of
hepatocytes and were able to maintain urea and albumin synthesis
up to at least one week following successful isolation. Successful
human hepatocyte isolations were defined as successful plating of
cells that were used in subsequent functional studies.
Liver samples from the normal liver category were histopatho-
gically evaluated on formalin fixed paraffin-embedded sections by
G.M.R. Steatosis was reported by the percentage of steatotic
hepatocytes present and group accordingly: minimal/none=
0–5%, mild=5–33%, moderate=33–66% and severe=.66%.
Urea Synthesis Assay
Confirmation of urea synthesis by isolated human hepatocytes
was performed using quantitative colorimetric urea determination
(QuantiChrom
TM urea assay kit-DIUR-500) (Bioassay Systems,
Hayward, CA, USA).
Albumin Synthesis Assay
Albumin synthesis by isolated human hepatocytes was con-
firmed using a sandwich ELISA kit (Abnova, CA, USA).
Immunostaining human hepatocytes for Cytokeratin 18
Following successful isolations, cytospins of hepatocytes were
made on Poly-L-lysine coated glass slides and fixed for 5 min in
acetone. Cells were then incubated with 20% normal rabbit serum
(Dako, Cambridge, UK) in Tris-buffered saline pH 7.4 (TBS) for
30 min. Monoclonal antibody to Cytokeratin 18 diluted 1:100
(clone DC10, Dako) or monoclonal antibody to Cytokeratin 19
diluted 1:100 (clone RCK108, Dako) or monoclonal antibody to
CD326 (Epithelial Cell Adhesion Molecule (EpCAM) diluted
1:100 (clone HEA125, Progen, Heidelberg, Germany) was applied
for 60 min, followed by polyclonal rabbit-anti mouse IgG antibody
(1:25 dilution, Dako) for 30 min and finally anti-alkaline
phosphatise (APAAP) complex (1:50 dilution in TBS) for
30 min. After each incubation step cytospins were washed x3 in
TBS. Antibody binding was visualised with 0.2 mg/ml naphthol-
AS-MX-phosphate dissolved in Dimethylforamide, (Sigma),
1 mg/ml Fast Red (Sigma) in 0.1 M Tris buffer (pH 8.2) and
0.25 mg/ml Levamisole (Sigma) for 15 min followed by counter-
staining with Mayer’s haematoxylin (Dako). Control cytospins
were included where primary antibody was substituted for isotype
matched immunglobulin. Slides were then mounted with Immu-
noblot mounting medium (Dako) and assessed for positivity.
Statistical Analysis
Univariable analysis was performed to test the effect of specific
factors upon outcome measures, human hepatocyte cell viability
following a preparation, total cell count after preparation and
success. Success was defined as maintenance of cell adherence and
morphological integrity 48 hours after plating onto type I rat
collagen and their subsequent use in functional studies. The
specific factors we analysed were hepatic disease type, time delay
between hepatectomy and beginning of the liver perfusion, weight
of liver wedge, perfusion time, the level of steatosis in the normal
liver cohort, and the use of Percoll enrichment. In univariable
analysis, Mann-Whitney tests were used for the time and weight
variables, as they did not to follow a normal distribution, with
Fisher’s Exact test being used for the categorical variables.
Multivariable analysis was performed by considering all specific
factors simultaneously and assessing the effect upon the said
outcome measures. For this analysis logistic regression models
were used.
Repeated-measures ANOVA was utilised to analyse the
synthesis of albumin and urea by human hepatocytes isolated
from normal, PBC/PSC, ALD and normal resected liver tissue.
Results
Liver wedges were prepared as shown in Figure 1 and processed
as detailed in the Methods section. Figure 2a shows representative
images of primary human hepatocytes, isolated from a liver with
PBC, in culture for the first week after isolation. Similar
morphological changes were observed during the first week after
successful cell isolation from normal, PSC, ALD and normal
resected liver tissue. Figure 2b demonstrates the morphological
features of primary human hepatocytes isolated from these various
livers 3 days after isolation. The morphology of primary human
hepatocytes after 3 days in culture was maintained for at least one
week after successful isolation.
The type of livers used and the main results of all human
hepatocyte isolations are shown in table 1. We processed and
Human Hepatocyte Isolation
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period. A variety of liver diseases were used including, as detailed
above, ALD, biliary cirrhosis (PBC and PSC), normal resected
liver and normal liver tissue (donor liver tissue, resections for
benign liver disease and cut-down specimens). A large proportion
of livers used in our study were from cirrhotic, end stage liver
diseases (54%). Normal resected liver tissue was defined as liver
tissue from patients with colorectal metastasis accounted for 26%
of livers used. All these latter patients had received pre-operative
chemotherapy for reduction of tumour mass prior to surgery.
Isolated cells from human liver tissue were all positive for the
hepatocyte cell marker, Cytokeratin 18 and were negative for the
biliary epithelial cell marker, Cytokeratin 19, and the hepatic
progenitor cell marker, CD326 (EpCAM) (Figure 3a). Further-
more, all hepatocytes isolated from normal and diseased liver
tissue demonstrated albumin and urea synthesis in the first week
after isolation (Figure 3b). Human hepatocytes isolated from
normal, normal resected and biliary cirrhosis showed significantly
increased albumin synthesis after two days in culture. Interestingly,
human hepatocytes isolated from ALD livers demonstrated
Figure 2. Morphology of Primary Human Hepatocytes after Isolation in Culture. (a) Comparison of the morphological appearance of
primary human hepatocytes isolated from primary biliary cirrhosis (PBC) attached to collagen-coated plates at (i) 2 hours after isolation (magnification
206), (ii) 1 day after isolation, (iii) 2 days after isolation, (iv) 3 days after isolation and (v) 7 days after isolation using light microscopy. The
representative images show the change in morphology of primary human hepatocytes isolated from PBC livers during 1-week in culture. Immediately
after isolation, cells appear ovoid and phase bright. Following 1 day in culture the cells appear binucleate and have formed a confluent monolayer.
Primary human hepatocytes maintain this morphology throughout the one week culture period. Similar morphological changes were observed for
human hepatocytes isolated from normal, ALD and normal resected liver tissue (data not shown). (b) Representative images of the morphology of
human hepatocytes isolated from normal, PBC/PSC, ALD and normal resected liver tissue are shown in culture 3 days after successful cell isolation.
Human hepatocytes demonstrated and maintained this morphology for at least one week following successful isolation. (i) Demonstrates the
morphology of human hepatocytes isolated from normal liver tissue and macro-steototic liver tissue (magnification 206). Primary human
hepatocytes isolated from normal liver tissue display the typical cubic binucleate cell morphology. In contrast, primary human hepatocytes isolated
from overtly macro-steatotic livers demonstrate obvious micro-vesicular steotosis. (ii) Human hepatocytes isolated from end stage biliary cirrhosis
(PBC/PSC) again show the typical features of cells in culture with a cubic and binucleate morphology. (iii–iv) Cells isolated from ALD and normal
resected liver show similar morphological features to human hepatocytes isolated from normal non-steatotic livers and biliary cirrhosis but also
exhibit micro-vesicular steatosis.
doi:10.1371/journal.pone.0018222.g002
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to other hepatocytes (p,0.05). Urea synthesis by human
hepatocytes demonstrated similar characteristics, with production
of urea being significantly greater on day 2 when compared to
other days in culture. Of note biliary cirrhosis and normal resected
human hepatocyte produce significantly more urea in culture
when compared to other human hepatocytes.
Absolute cell count after isolation was an important parameter
on which to assess efficacy of the procedure. Univariable analysis
revealed that disease type (p,0.001, Fisher’s Exact test) was the
only factor to have a significant bearing upon total cell count after
primary isolation. Multivariable analysis showed that ALD livers
have a significantly lower cell yield when compared to other liver
categories (p,0.15 – table 1).
Overall, for all human hepatocyte isolations we report a median
cell viability of 40%. Human hepatocytes isolated from biliary
cirrhosis (PBC and PSC) had the highest median cell viability
(55%). Univariable and Multivariable analysis showed the only
factor which had an effect upon improving cell viability was the
time delay between hepatectomy and beginning of the perfusion
procedure (p,0.05, Mann-Whitney test). Complete processing
within 3 hours resulted in a significantly higher cell viability
(.50%), compared to time delays greater than 5 hours (p,0.05,
Odds Ratio =3.594). Whether the delay is 3–5 hours or more
Figure 3. Immunostaining of Cytokeratin 18, Cytokeratin 19 and CD326 and Metabolic Activity of Primary Human Hepatocytes
Isolated from Normal and Diseased Liver Tissue. (a) Human hepatocytes isolated from normal, PBC, ALD and normal resected liver tissue show
strong staining for the intracellular hepatocyte marker Cytokeratin 18 (CK18). In contrast, isotype matched controls immunoglobulin showed no
positivity. Furthermore, isolated human hepatocytes showed no staining with the biliary epithelial cell marker Cytokeratin 19 (CK19) or hepatic
progenitor cell marker CD326 (EpCAM). Cytospins of human hepatocytes were made immediately after successful cell isolation, fixed in acetone for
5 min and stored at 220uC until immuno-staining was performed. (b) Following successful isolation, human hepatocytes isolated from normal, PBC/
PSC, ALD or normal resected liver tissue were able to synthesise albumin (i) for at least one week demonstrating active metabolic activity in culture.
Human hepatocytes isolated from normal, PBC/PSC and normal resected liver tissue show significantly greater albumin synthesis after two days in
culture (*p,0.05). Morover, human hepatocytes isolated from ALD livers synthesised significantly less albumin than other types of human
hepatocytes (p,0.05). In addition, human hepatocytes isolated from normal resected liver tissue synthesised significantly greater amounts of
albumin than normal hepatocytes (p,0.037). (n=3–4 separate samples). Human hepatocytes isolated from normal, PBC/PSC, ALD and normal
resected liver tissue were also able to synthesise urea (ii) for at least one week following successful cell isolation. Human hepatocytes isolated from
both normal and diseased liver tissue synthesised significantly lower levels of urea one day after isolation (1p,0.001) compared to the remainder of
the culture period, but all human hepatocytes produced significantly more urea on day 2 when compared to other days (*p,0.001). Finally, PBC/PSC
and normal resected human hepatocyte synthesis significantly greater amounts of urea when compared to the other human hepatocytes (p,0.05)
but there was no significant difference between PBC/PSC and resected human hepatocytes. (n=3–4 separate samples).
doi:10.1371/journal.pone.0018222.g003
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cellviability being greater than50% (p=0.375, OddsRatio =1.725).
These data are summarised in Table 2. In our study we used Percoll
density gradient centrifugation toenrich hepatocytes purity wherecell
viability was low but absolute cell count high (n=8). These data are
summarised in Table 3. Percoll enhanced purity of human
hepatocyte isolates but at the expense of cell count, hence the need
for a relatively high absolute cell count after the initial liver
preparation.
We assigned all donor liver tissue, resections performed for
benign liver disease (recurrent cholangitis, focal nodular hyper-
plasia and haemangiomas) and cut down specimens as ‘normal’
liver tissue. These livers had no signs of intrinsic liver disease. This
group was analysed as a whole and as a sub-group, where donor
liver tissue was compared to normal liver tissue (resections from
benign liver disease and cut down specimens). Sub-group analysis
was carried out to determine whether the level of steatosis had an
effect upon absolute cell count, cell viability and success rate of
subsequent culture. The level of steatosis in the two groups is
shown in Table 4. We found no difference in absolute cell count,
cell viability, and success rate between the donor liver and normal
liver groups. The success of isolating human hepatocytes from this
group as a whole was good (53%) but normal liver tissue obtained
from hepatic resections carried out for benign disease and cut-
down specimens had a statistically higher success rate (64%) when
compared to donor liver tissue (20%).
Our series is the largest reported of human hepatocyte isolations
from cirrhotic livers (n=55). We report a median success rate
when isolating hepatocytes from cirrhotic livers of 45%. Table 1
shows that liver wedges from biliary cirrhosis (PBC and PSC) had
the highest success rate of all livers used in our study (71%). For all
liver isolations, univariate analysis showed a significant difference
in time delay between hepatectomy and beginning of liver
perfusion (p,0.001, Mann-Whitney test), perfusion time
(p,0.05, Mann-Whitney test) and disease type (p,0.05, Fisher’s
Exact test) between the groups of successful and unsuccessful
isolations. Multivariable analysis revealed disease type (p,0.05)
and time delay between hepatectomy and beginning of perfusion
(p,0.05) were significant factors affecting successful human
hepatocyte isolation. As described above for cell viability, success
is significantly dependent upon time delay (p,0.01), with a delay
of less than 3 hours resulting in improved success rates compared
to those of more than 5 hours (p,0.05, Odds Ratio =3.735).
Discussion
The preparation of primary human hepatocytes is a time
consuming, logistically demanding, and expensive process. The
demand for high quality human hepatocytes for cell transplanta-
tion and pharmo-toxicological studies continues to rise. However,
the availability of human liver tissue for laboratory investigation
remains limited. Therefore, cirrhotic end-stage livers, which are
more readily available to researchers, represent another potential
source of human hepatocytes. We know of no other studies which
evaluate and compare the outcome of human hepatocytes isolation
Table 1. The Type of Livers used and the Main Results of All Human Hepatocyte Isolations.
Liver Type
Time Delay
(hrs)
Weight
(g)
Perfusion Time
(min)
Absolute Cell Count
After Perfusion
610
3
Viability
(%)
Success Rate
(%)
Normal (n=21) 2.5
(1–14)
110
(66–413)
1.5
(1–11)
57
(75–200,000)
46
(0–100)
53
Donor Liver (n=7) 4
(2–14)
117
(101–150)
1.5
(1–11)
1500
(75–200,000)
20
(0–60)
29
Normal Liver (n=14) 2
(1–4)
105
(66–413)
2
(1–7)
505
(75–32,000)
50
(10–100)
64
Resected (n=27) 2.5
(1–16)
90
(50–180)
1.5
(1–5)
220
(50–6,000)
50
(0–100)
53
Biliary Cirrhosis (n=24) 2
(1–11)
106
(78–200)
1.5
(1–8.5)
720
(200–7,000)
55
(0–100)
71*
ALD (n=24) 2.5
(1–13)
110
(64–220)
3
(1–19)
155{
(20–3,000)
40
(0–100)
29
Others (n=8) 4.5
(1–12)
101
(56–115)
5.5
(3–17)
225
(40–3,000)
7.5
(0–70)
13
TOTAL (104) 2
(1–16)
110
(50–413)
2.5
(1–19)
350
(20–200,000)
40
(0–100)
51
The time delay, weight of liver wedges, perfusion time, absolute cell count after perfusion, cell viability and success rate are shown for various liver categories; Normal
(donor liver tissue, normal benign tissue and cut-down specimens), normal resected liver tissue, biliary tissue (PBC and PSC), ALD and others (cystic fibrosis 2,
cryptogenic fibrosis 2, alpha-1-antitypsin deficiency 1, autoimmune hepatitis 1 and non-alcoholic steatohepatitis 2). All values are represented as medians and the
values in parentheses represent the range. n, number of cases.
{p,0.05, multivariable analysis showing ALD livers yield significantly lower cell yields when compared to other liver diseases.
*p,0.05, multivariable analysis showing biliary cirrhosis yielded a higher success rate of human hepatocyte isolation when compared to other liver diseases.
doi:10.1371/journal.pone.0018222.t001
Table 2. Effect of Time Delay Between Hepatectomy and
Beginning of the Perfusion Procedure Upon Human
Hepatocyte Cell Viability Following Isolation Procedure.
Time Delay (hrs) Median Cell Viability (%)
,35 3
3–5 25
.52 0
doi:10.1371/journal.pone.0018222.t002
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standard isolation protocol. Our experience highlights that the
isolation of primary human hepatocytes from normal or diseased
livers is a viable proposition given appropriate methods.
Our data confirm that isolating human hepatocytes from ALD
livers is technically challenging and we had a success rate of only
29%. Thus the use of ALD livers for hepatocyte isolation is a
questionable proposition. This may in part be explained by the
variable disease stage of our ALD cohort which included patients
with advanced cirrhosis or it may reflect toxicological damage
resulting from the effects of alcohol. Excluding the ‘other’ disease
categories, ALD livers had the longest median perfusion time
again presumably reflecting that these livers were from patients
with more advanced liver cirrhosis. Moreover, human hepatocytes
isolated from ALD demonstrate significantly less albumin
production when compared to the other human hepatocytes
supporting the hypothesis that prior alcohol exposure may affect
the function of these hepatocytes. Our data further highlight that
tissue from patients with biliary cirrhosis (PBC or PSC) provides
high yields of hepatocytes (success rate 71%). Furthermore, such
hepatocytes demonstrate the highest levels of albumin and urea
production. As discussed below, this success rate was similar to that
we obtained using non-diseased liver tissue. In biliary cirrhosis
cytoprotective agents such as ursodeoxycholic acid (UDCA) are
routinely used therapeutically. The ability of UDCA to inhibit the
accumulation of reactive oxygen species (ROS) [15] and its known
anti-apoptotic effects may provide hepato-protection [16]. Indeed
in our reported series all patients with biliary cirrhosis were taking
UDCA at the time of liver transplantation. Thus UDCA may
promote human hepatocytes isolation in an analogous way to that
suggested for the antioxidant, N-acetylcysteine (NAC) [3].
Conversely, alcohol consumption increases ROS production
which instigates hepatocyte injury during ALD [17] as well as
inducing toxic metabolites and cytokines that perpetuate hepato-
cyte injury. It is thus possible that hepatocytes from patients with
ALD are sensitised to the cellular stress induced by enzymes used
in the digestion process resulting in increased hepatocyte cell death
and lower cell viability and yields. The yields from end-stage
cirrhotic livers other than ALD and biliary cirrhosis were very
poor results (success rate 13%) and we would not recommend the
routine use of such livers for cell isolation.
We report a success rate of 53% for hepatocyte isolation from
normal resected livers, which is lower than that reported by other
authors [7,18]. There are several potential explanations for this.
Other studies used different enzyme cocktails and may have been
more selective when deciding which livers to process [1]. Recent
studies have used the enzyme liberase to isolate hepatocytes from
normal resected liver tissue and have reported higher cell
viabilities and cell yields [1]. We concur with previous authors
that normal resected tissue is a good source of human hepatocytes.
However, our recent study suggests that human hepatocytes
isolated from normal resected liver tissue may differ functionally in
their response to physiological stimuli [4]. Most authors have
previously assumed that the function of human hepatocytes
isolated from normal liver tissue was consistent between different
sources [18]. In light of our findings further functional analyses of
human hepatocytes isolated from different liver diseases should be
carried out before conclusions can be drawn about their
‘normality’.
The isolations we carried out using liver wedges from benign
resections and cut down specimens gave good success rates (64%)
comparedtodonorlivertissue(29%)consistentwithresultsreported
by others [7]. The donor livers used in our study had been turned
down for transplantation as a result of macrosteatosis and as
Figure 2b demonstrates human hepatocytes from these steatotic
livers also exhibit micro-vesicular steatosis. Within the steatotic
livers the rate of successful hepatocyte isolation was greater than in
those with mild compared with moderate or severe steatosis (70%
vs. 20%). Previous authors have also noted that high degrees of
steatosis generally did not favour successful cell isolation [6,7].
Steatotic hepatocytes have higher intracellular ROS levels and are
thus potentially more susceptible to damage [3]. The recent work of
Sagias et al suggests that the additionof NAC to perfusion fluidsmay
improve hepatocyte yields from steatotic livers. Another, contrib-
utory factor for the lower viability and yield of hepatocytes from
donor liver is the longer cold ischaemic time that donor livers have
been exposed to when compared to normal livers (Table 1).
Previous authors have suggested that the optimal liver wedge
weight for human hepatocyte isolation is approximately 100 g. We
agree with this and in the present study the majority of liver
wedges were between 80–120 g. In our study a median perfusion
time of 2.5 min was required to digest the livers, as judged by the
admission of a digit into the liver substance. Other studies report
digestion times ranging from 20–47 min (1) [19]. This could
simply be a reflection of different enzyme types, concentrations or
differences between batches. In our series the same enzyme
batches were used for all isolations. The enzyme cocktail we used
allowed isolation of cells from end-stage cirrhotic livers and it is
possible that this enzyme concentration may be excessive for
normal resected and donor liver tissue thereby contributing to our
low yield and viability compared with other reports.
Although perfusion time was significant in the univariable
analysis it fell out during multivariable analysis. The reason for this
Table 3. Effect of Percoll upon Cell Viability and Absolute Cell
Count.
Absolute Cell
Count after
Preparation
610
3
Viability
(%)
Absolute Cell
Count after
Percoll
610
3
Viability after
Percoll
(%)
550
(200–200,000)
35
(10–50)
175
(100–400)
85
(55–90)
The effects of Percoll upon human hepatocyte isolation procedures. We used
Percoll after eight human hepatocyte isolation procedures (normal resected
liver tissue 1, biliary cirrhosis 5, donor liver tissue 1 and normal benign liver
tissue 1). All values are represented as medians and the values in parentheses
represent the range.
doi:10.1371/journal.pone.0018222.t003
Table 4. The Level of Steatosis in Liver Wedges taken from
Donor Liver Tissue and Normal Liver Tissue.
Minimal/
None Mild Moderate Severe
Donor liver tissue
(n=6)
11 3 1
Normal liver tissue
(n=12)
10 1 1 -
The level of steatosis in liver wedges taken from normal liver tissue. The level of
steatosis was classified as minimal/none=0–5%, mild=5–33%, moderate=33–
66% and severe=$66% after histological analysis of paraffin embedded
sections. We were unable to classify the level of steatosis in three liver wedges
(1 donor liver and 2 normal livers) as the tissue from those particular livers was
not available. n, number of cases.
doi:10.1371/journal.pone.0018222.t004
Human Hepatocyte Isolation
PLoS ONE | www.plosone.org 7 March 2011 | Volume 6 | Issue 3 | e18222is likely to be correlation with the time delay between hepatectomy
and beginning of liver perfusion (Spearman’s Rho =.377,
p,.001) which remained significant even after adjusting for
perfusion time.
Thus we provide evidence to suggest that the time delay
between hepatectomy and beginning of liver perfusion should be
kept to less than 3 hours. From our experience of isolating human
hepatocytes from cirrhotic livers after an initial learning curve the
operator becomes skilled at recognising when adequate digestion
has occurred thereby avoiding overdigestion of tissue.
In conclusion, we report that the time delay between
hepatectomy and beginning of liver perfusion is the most
important factor in determining the likelihood of success of the
procedure. Furthermore, we suggest the shortest possible digestion
time is desirable. If protocols similar to ours are followed human
hepatocytes can be isolated successfully from normal and diseased
liver tissue.
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